08:00 , Feb 18, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Indication

Indication Target/marker/pathway Summary Licensing status Publication and contact information Autoimmune disease Multiple sclerosis (MS) CD200 receptor 1 (CD200R1) A study in mice suggests that CD200R1 agonists could help treat chronic MS. In a mouse model...